Source: Annual Congress 2011 - Asthma management and response
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
M. L. Zaremba, K. Elliott, A. Redford, N. Shah, S. Ali, S. Reddy (Port Huron, United States Of America). Quantitative IgE levels in asthma and implications for treatment with omalizumab. Are the cutoffs to narrow?. Eur Respir J 2011; 38: Suppl. 55, 3962

Member's Comments

No comment yet.

Related content which might interest you: Treatment of asthma above and beyond anti IgE: an update for the clinician The use of biologicals in asthma treatment Source: International Congress 2018 – Difficult paediatric lung disease Year: 2018 Free serum IgE suppression with omalizumab and clinical outcomes in asthma Source: International Congress 2019 – Clinical studies of asthma treatments Year: 2019 Correlation between specific serum IgE and exhaled NO levels at low and high inhaled corticosteroid use in allergic asthma Source: Eur Respir J 2005; 26: Suppl. 49, 276s Year: 2005 Long-term efficacy of omalizumab (OMA) for patients with severe allergic asthma (SAA). Clinical assessment and relationship to serum IgE concentrations Source: International Congress 2015 – The immunology of allergic airway disease Year: 2015 Relationship between omalizumab efficacy and baseline allergen profile impacts patient-reported outcomes in allergic asthma Source: International Congress 2018 – Tests and trends in asthma Year: 2018 Correlation of changes of IgE with skin reactivity and clinical outcome during specific immunotherapy against home dust in asthmatic subjects Source: Annual Congress 2012 - Phenotypes and mechanisms of treatment of asthma Year: 2012 Clinical significance of serum MRGPRX2 as a new biomarker in allergic asthma Source: International Congress 2019 – Research and innovation in airway diseases Year: 2019 Returning asthma symptoms correlate with free IgE upon omalizumab cessation Source: Annual Congress 2007 - Improving asthma therapy - new findings in established and experimental treatment modalities Year: 2007 Possible impact of serum IgE variability on dose calculation of omalizumab (anti-IgE) Source: Eur Respir J 2004; 24: Suppl. 48, 220s Year: 2004 Monitoring free serum IgE in asthma patients treated with omalizumab Source: Annual Congress 2010 - Asthma: clinical aspects and treatment Year: 2010 Impact of omalizumab treatment persistence on asthma control Source: Annual Congress 2012 - Aspects of clinical asthma Year: 2012 Effect of urbanisation on the relationship between total serum IgE and asthma Source: Eur Respir J 2013; 41: 1074-1081 Year: 2013 Relationship between pre-treatment specific IgE and the response to omalizumab therapy Source: Annual Congress 2008 - Improving asthma and anti-allergic therapy Year: 2008 Measuring airway hyperresponsiveness: does it add to routine measures of clinical efficacy in guiding asthma therapy? Source: Eur Respir J 2006; 28: Suppl. 50, 319s Year: 2006 Real life effectiveness of omalizumab in severe allergic asthma, does the IgE level matter? A Bradford experience Source: Annual Congress 2013 –Treatment of asthma Year: 2013 Optimal cut-off value and clinical usefulness of adherence starts with knowledge-12 (ASK-12) in asthmatic patients taking inhaled corticosteroid Source: International Congress 2016 – Notable abstracts on clinical problems related to asthma Year: 2016 Anti-IgE: lessons from clinical trials in patients with severe allergic asthma symptomatic despite optimised therapy Source: Eur Respir Rev 2007; 16: 73-77 Year: 2007 Monitoring free serum IgE in severe asthma patients treated with omalizumab Source: Annual Congress 2011 - Biomarkers and exacerbations of asthma and COPD Year: 2011 How specific and sensitive are commercial specific IgE assays in the diagnosis of occupational asthma and allergy? Source: Annual Congress 2009 - Occupational asthma in the clinic Year: 2009 Long-term bortezomib treatment decreases allergen-specific IgE but fails to amend chronic asthma in mice Source: Annual Congress 2012 - Asthma: mechanisms of airway inflammation Year: 2012